RANITIDINE HCL (RANITIDINE HCL)
- Dyspepsia
- Erosive esophagitis
- Heartburn
- Duodenal ulcer
- Gastric hypersecretion with systemic mastocytosis
- Gastric ulcer
- Gastroesophageal reflux disease
- Maintenance of healing duodenal ulcer
- Maintenance of healing erosive esophagitis
- Maintenance of healing gastric ulcer
- Multiple endocrine neoplasia
- Pathological gastric acid hypersecretory condition
- Zollinger-ellison syndrome
- Zantac Tablet
- Zantac Maximum Strength Tablet
- Zantac 75 Tablet
- Wal-zan 75 Tablet
- Wal-zan 150 Tablet
- Ranitidine Tablet
- Ranitidine Syrup
- Ranitidine Oral Syrup
- Ranitidine Capsule
- Heartburn Relief (ranitidine) Tablet
- Acid Reducer (ranitidine) Tablet
- Acid Control (ranitidine) Tablet
- By Indication
150 mg tablet
- 1 tablet (150 mg) by oral route 2 times per day
Maximum Strength 150 mg tablet
- 1 tablet (150 mg) by oral route 2 times per day
mg tablet
- 1 tablet (75 mg) by oral route 2 times per day with glass of water
75 mg tablet
- 1 tablet (75 mg) by oral route 2 times per day with glass of water
150 mg tablet
- 1 tablet (150 mg) by oral route 2 times per day
ranitidine 150 mg tablet
- 1 tablet (150 mg) by oral route 2 times per day
ranitidine 300 mg tablet
- 1 tablet (300 mg) by oral route once daily at bedtime
ranitidine 75 mg tablet
- 1 tablet (75 mg) by oral route 2 times per day with glass of water
ranitidine 15 mg/mL oral syrup
- 10 milliliters (150 mg) by oral route 2 times per day
ranitidine 15 mg/mL oral syrup
- 10 milliliters (150 mg) by oral route 2 times per day
ranitidine 150 mg capsule
- 1 capsule (150 mg) by oral route 2 times per day
ranitidine 300 mg capsule
- 1 capsule (300 mg) by oral route once daily at bedtime
(ranitidine) 150 mg tablet
- 1 tablet (150 mg) by oral route 2 times per day
(ranitidine) 75 mg tablet
- 1 tablet (75 mg) by oral route 2 times per day with glass of water
150 mg tablet
- 1 tablet (150 mg) by oral route 2 times per day
75 mg tablet
- 1 tablet (75 mg) by oral route 2 times per day with glass of water
Heartburn Relief (ranitidine) 150 mg tablet
- 1 tablet (150 mg) by oral route 2 times per day
Heartburn Relief (ranitidine) 75 mg tablet
- 1 tablet (75 mg) by oral route 2 times per day with glass of water
(ranitidine) 150 mg tablet
- 1 tablet (150 mg) by oral route 2 times per day
(ranitidine) 75 mg tablet
- 1 tablet (75 mg) by oral route 2 times per day with glass of water
150 mg tablet
- 1 tablet (150 mg) by oral route 2 times per day
75 mg tablet
- 1 tablet (75 mg) by oral route 2 times per day with glass of water
Acid Reducer (ranitidine) 150 mg tablet
- 1 tablet (150 mg) by oral route 2 times per day
Acid Reducer (ranitidine) 75 mg tablet
- 1 tablet (75 mg) by oral route 2 times per day with glass of water
(ranitidine) 150 mg tablet
- 1 tablet (150 mg) by oral route 2 times per day
Duodenal ulcer
- 10 milliliters (150 mg) by oral route 2 times per day
- 1 tablet (150 mg) by oral route 2 times per day
- 1 capsule (150 mg) by oral route 2 times per day
- 2 capsules (300 mg) by oral route once daily at bedtime
- 20 milliliters (300 mg) by oral route once daily at bedtime
- 1 tablet (300 mg) by oral route with the evening meal
- 1 tablet (300 mg) by oral route once daily at bedtime
- 2 tablets (300 mg) by oral route once daily at bedtime
- 1 capsule (300 mg) by oral route once daily at bedtime
- 2 capsules (300 mg) by oral route once daily after evening meal
- 1 capsule (300 mg) by oral route once daily after evening meal
Dyspepsia
- 2 tablets (150 mg) by oral route every 12 hours
Erosive esophagitis
- 10 milliliters (150 mg) by oral route 4 times per day
- 1 tablet (150 mg) by oral route 4 times per day
- 1 capsule (150 mg) by oral route 4 times per day
Gastric hypersecretion with systemic mastocytosis
- 10 milliliters (150 mg) by oral route 2 times per day
- 1 tablet (150 mg) by oral route 2 times per day
- 1 capsule (150 mg) by oral route 2 times per day
- 1 capsule (300 mg) by oral route 2 times per day
- 1 tablet (300 mg) by oral route 2 times per day
- 2 tablets (600 mg) by oral route 2 times per day
Gastric ulcer
- 10 milliliters (150 mg) by oral route 2 times per day
- 1 tablet (150 mg) by oral route 2 times per day
- 1 capsule (150 mg) by oral route 2 times per day
Gastroesophageal reflux disease
- 10 milliliters (150 mg) by oral route 2 times per day
- 1 tablet (150 mg) by oral route 2 times per day
- 1 capsule (150 mg) by oral route 2 times per day
Heartburn
- 1 tablet (75 mg) by oral route once daily with glass of water
- 1 tablet (75 mg) by oral route 2 times per day with glass of water
- 10 milliliters (150 mg) by oral route 4 times per day
- 1 tablet (150 mg) by oral route 4 times per day
- 10 milliliters (150 mg) by oral route 2 times per day
- 1 capsule (150 mg) by oral route 4 times per day
- 1 tablet (150 mg) by oral route 2 times per day
- 1 capsule (150 mg) by oral route 2 times per day
Maintenance of healing duodenal ulcer
- 1 tablet (150 mg) by oral route once daily at bedtime
- 10 milliliters (150 mg) by oral route once daily at bedtime
- 1 capsule (150 mg) by oral route once daily at bedtime
Maintenance of healing erosive esophagitis
- 10 milliliters (150 mg) by oral route 2 times per day
- 1 tablet (150 mg) by oral route 2 times per day
- 1 capsule (150 mg) by oral route 2 times per day
Maintenance of healing gastric ulcer
- 1 tablet (150 mg) by oral route once daily at bedtime
- 10 milliliters (150 mg) by oral route once daily at bedtime
- 1 capsule (150 mg) by oral route once daily at bedtime
Multiple endocrine neoplasia
- 10 milliliters (150 mg) by oral route 2 times per day
- 1 tablet (150 mg) by oral route 2 times per day
- 1 capsule (150 mg) by oral route 2 times per day
- 1 capsule (300 mg) by oral route 2 times per day
Pathological gastric acid hypersecretory condition
- 10 milliliters (150 mg) by oral route 2 times per day
- 1 tablet (150 mg) by oral route 2 times per day
- 1 capsule (150 mg) by oral route 2 times per day
- 1 capsule (300 mg) by oral route 2 times per day
- 1 tablet (300 mg) by oral route 2 times per day
- 2 tablets (600 mg) by oral route 2 times per day
Zollinger-ellison syndrome
- 10 milliliters (150 mg) by oral route 2 times per day
- 1 tablet (150 mg) by oral route 2 times per day
- 1 capsule (150 mg) by oral route 2 times per day
- 1 capsule (300 mg) by oral route 2 times per day
- 1 tablet (300 mg) by oral route 2 times per day
- 2 tablets (600 mg) by oral route 2 times per day
- None
Contraindicated
- itraconazole
- ketoconazole
- Onmel
- Sporanox
- Sporanox Pulsepak
Severe
Moderate
- Adderall
- Adderall Xr
- Amphetamine Salt Combo
- Anti-diarrhea
- Anti-diarrheal (lope)-anti-gas
- Anti-diarrheal (loperamide)
- atazanavir
- Ceftin
- cefuroxime axetil
- Cerebyx
- Complera
- Dexedrine Spansule
- dextroamphetamine
- dextroamphetamine-amphetamine
- Diamode
- Dilantin
- Dilantin Extended
- Dilantin Infatabs
- Dilantin Kapseal
- Dilantin-125
- Edurant
- emtricitab-rilpivirine-tenofov
- ethotoin
- fosphenytoin
- Imodium Multi-symptom Relief
- Isentress
- Juxtapid
- Lo-peramide
- lomitapide
- loperamide
- loperamide-simethicone
- Peganone
- Phenytek
- phenytoin
- phenytoin sodium
- phenytoin sodium extended
- Procentra
- raltegravir
- Reyataz
- rilpivirine
- Ultra A-d
- Zenzedi
- None
Contraindicated
- Porphyria
Severe
Moderate
- Disease of liver
- Gastric cancer
- Kidney disease with reduction in GFR
RANITIDINE HCL (RANITIDINE HCL)
- Dyspepsia
- Erosive esophagitis
- Heartburn
- Duodenal ulcer
- Gastric hypersecretion with systemic mastocytosis
- Gastric ulcer
- Gastroesophageal reflux disease
- Maintenance of healing duodenal ulcer
- Maintenance of healing erosive esophagitis
- Maintenance of healing gastric ulcer
- Multiple endocrine neoplasia
- Pathological gastric acid hypersecretory condition
- Zollinger-ellison syndrome
- None
- None
More Frequent
Severe
Less Severe
- None
- Abdominal pain with cramps
- Constipation
- Diarrhea
- Dizziness
- Drowsy
- Headache disorder
- Nausea
- Skin rash
- Vomiting
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Abnormal hepatic function tests
- Acute confusion
- Acute pancreatitis
- Agitation
- Agranulocytosis
- Angioedema
- Atrioventricular block
- Blurred vision
- Bradycardia
- Bronchospastic pulmonary disease
- Cardiac arrhythmia
- Depression
- Erythema multiforme
- Extrasystoles
- Fever
- Hallucinations
- Hemolytic anemia
- Hepatitis
- Hypersensitivity drug reaction
- Interstitial nephritis
- Jaundice
- Leukopenia
- Malaise
- Neutropenic disorder
- Pancytopenia
- Pneumonia
- Tachycardia
- Thrombocytopenic disorder
- Vasculitis
- Ventricular premature beats
Less Severe
- Alopecia
- Arthralgias
- Insomnia
- Myalgias
- Vertigo
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
Ranitidine
- Severity Level:
B
- Additional Notes:
Contraindicated
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Precaution Exists
Ranitidine
Low amounts excreted not likely to result in infant adv effects
General | Excretion Potential | Effect on Infant | Notes |
Evaluate use carefully | Excreted | Not known; no or inclusive data | Low amounts excreted not likely to result in infant adv effects |
No Known Risk
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
Duodenal ulcer | |
K26 | Duodenal ulcer |
K26.0 | Acute duodenal ulcer with hemorrhage |
K26.1 | Acute duodenal ulcer with perforation |
K26.2 | Acute duodenal ulcer with both hemorrhage and perforation |
K26.3 | Acute duodenal ulcer without hemorrhage or perforation |
K26.4 | Chronic or unspecified duodenal ulcer with hemorrhage |
K26.5 | Chronic or unspecified duodenal ulcer with perforation |
K26.6 | Chronic or unspecified duodenal ulcer with both hemorrhage and perforation |
K26.7 | Chronic duodenal ulcer without hemorrhage or perforation |
K26.9 | Duodenal ulcer, unspecified as acute or chronic, without hemorrhage or perforation |
Dyspepsia | |
K30 | Functional dyspepsia |
Erosive esophagitis | |
K22.1 | Ulcer of esophagus |
K22.10 | Ulcer of esophagus without bleeding |
K22.11 | Ulcer of esophagus with bleeding |
Gastric hypersecretion with systemic mastocytosis | |
C96.21 | Aggressive systemic mastocytosis |
D47.02 | Systemic mastocytosis |
K31.89 | Other diseases of stomach and duodenum |
Gastric ulcer | |
K25 | Gastric ulcer |
K25.0 | Acute gastric ulcer with hemorrhage |
K25.1 | Acute gastric ulcer with perforation |
K25.2 | Acute gastric ulcer with both hemorrhage and perforation |
K25.3 | Acute gastric ulcer without hemorrhage or perforation |
K25.4 | Chronic or unspecified gastric ulcer with hemorrhage |
K25.5 | Chronic or unspecified gastric ulcer with perforation |
K25.6 | Chronic or unspecified gastric ulcer with both hemorrhage and perforation |
K25.7 | Chronic gastric ulcer without hemorrhage or perforation |
K25.9 | Gastric ulcer, unspecified as acute or chronic, without hemorrhage or perforation |
Gastroesophageal reflux disease | |
K21 | Gastro-esophageal reflux disease |
K21.0 | Gastro-esophageal reflux disease with esophagitis |
K21.9 | Gastro-esophageal reflux disease without esophagitis |
Heartburn | |
R12 | Heartburn |
Maintenance of healing duodenal ulcer | |
K26 | Duodenal ulcer |
K26.0 | Acute duodenal ulcer with hemorrhage |
K26.1 | Acute duodenal ulcer with perforation |
K26.2 | Acute duodenal ulcer with both hemorrhage and perforation |
K26.3 | Acute duodenal ulcer without hemorrhage or perforation |
K26.4 | Chronic or unspecified duodenal ulcer with hemorrhage |
K26.5 | Chronic or unspecified duodenal ulcer with perforation |
K26.6 | Chronic or unspecified duodenal ulcer with both hemorrhage and perforation |
K26.7 | Chronic duodenal ulcer without hemorrhage or perforation |
K26.9 | Duodenal ulcer, unspecified as acute or chronic, without hemorrhage or perforation |
Maintenance of healing erosive esophagitis | |
K22.1 | Ulcer of esophagus |
K22.10 | Ulcer of esophagus without bleeding |
K22.11 | Ulcer of esophagus with bleeding |
Maintenance of healing gastric ulcer | |
K25 | Gastric ulcer |
K25.0 | Acute gastric ulcer with hemorrhage |
K25.1 | Acute gastric ulcer with perforation |
K25.2 | Acute gastric ulcer with both hemorrhage and perforation |
K25.3 | Acute gastric ulcer without hemorrhage or perforation |
K25.4 | Chronic or unspecified gastric ulcer with hemorrhage |
K25.5 | Chronic or unspecified gastric ulcer with perforation |
K25.6 | Chronic or unspecified gastric ulcer with both hemorrhage and perforation |
K25.7 | Chronic gastric ulcer without hemorrhage or perforation |
K25.9 | Gastric ulcer, unspecified as acute or chronic, without hemorrhage or perforation |
K27 | Peptic ulcer, site unspecified |
K27.0 | Acute peptic ulcer, site unspecified, with hemorrhage |
K27.1 | Acute peptic ulcer, site unspecified, with perforation |
K27.2 | Acute peptic ulcer, site unspecified, with both hemorrhage and perforation |
K27.3 | Acute peptic ulcer, site unspecified, without hemorrhage or perforation |
K27.4 | Chronic or unspecified peptic ulcer, site unspecified, with hemorrhage |
K27.5 | Chronic or unspecified peptic ulcer, site unspecified, with perforation |
K27.6 | Chronic or unspecified peptic ulcer, site unspecified, with both hemorrhage and perforation |
K27.7 | Chronic peptic ulcer, site unspecified, without hemorrhage or perforation |
K27.9 | Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation |
K28 | Gastrojejunal ulcer |
K28.0 | Acute gastrojejunal ulcer with hemorrhage |
K28.1 | Acute gastrojejunal ulcer with perforation |
K28.2 | Acute gastrojejunal ulcer with both hemorrhage and perforation |
K28.3 | Acute gastrojejunal ulcer without hemorrhage or perforation |
K28.4 | Chronic or unspecified gastrojejunal ulcer with hemorrhage |
K28.5 | Chronic or unspecified gastrojejunal ulcer with perforation |
K28.6 | Chronic or unspecified gastrojejunal ulcer with both hemorrhage and perforation |
K28.7 | Chronic gastrojejunal ulcer without hemorrhage or perforation |
K28.9 | Gastrojejunal ulcer, unspecified as acute or chronic, without hemorrhage or perforation |
P78.82 | Peptic ulcer of newborn |
Multiple endocrine neoplasia | |
E31.2 | Multiple endocrine neoplasia [MEn] syndromes |
E31.20 | Multiple endocrine neoplasia [MEn] syndrome, unspecified |
E31.21 | Multiple endocrine neoplasia [MEn] type I |
E31.22 | Multiple endocrine neoplasia [MEn] type IIA |
E31.23 | Multiple endocrine neoplasia [MEn] type IIB |
Pathological gastric acid hypersecretory condition | |
K31.89 | Other diseases of stomach and duodenum |
Zollinger-ellison syndrome | |
E16.4 | Increased secretion of gastrin |
0-9 | A-Z |
---|---|
C96.21 | Aggressive systemic mastocytosis |
D47.02 | Systemic mastocytosis |
E16.4 | Increased secretion of gastrin |
E31.2 | Multiple endocrine neoplasia [MEn] syndromes |
E31.20 | Multiple endocrine neoplasia [MEn] syndrome, unspecified |
E31.21 | Multiple endocrine neoplasia [MEn] type I |
E31.22 | Multiple endocrine neoplasia [MEn] type IIA |
E31.23 | Multiple endocrine neoplasia [MEn] type IIB |
K21 | Gastro-esophageal reflux disease |
K21.0 | Gastro-esophageal reflux disease with esophagitis |
K21.9 | Gastro-esophageal reflux disease without esophagitis |
K22.1 | Ulcer of esophagus |
K22.1 | Ulcer of esophagus |
K22.10 | Ulcer of esophagus without bleeding |
K22.10 | Ulcer of esophagus without bleeding |
K22.11 | Ulcer of esophagus with bleeding |
K22.11 | Ulcer of esophagus with bleeding |
K25 | Gastric ulcer |
K25 | Gastric ulcer |
K25.0 | Acute gastric ulcer with hemorrhage |
K25.0 | Acute gastric ulcer with hemorrhage |
K25.1 | Acute gastric ulcer with perforation |
K25.1 | Acute gastric ulcer with perforation |
K25.2 | Acute gastric ulcer with both hemorrhage and perforation |
K25.2 | Acute gastric ulcer with both hemorrhage and perforation |
K25.3 | Acute gastric ulcer without hemorrhage or perforation |
K25.3 | Acute gastric ulcer without hemorrhage or perforation |
K25.4 | Chronic or unspecified gastric ulcer with hemorrhage |
K25.4 | Chronic or unspecified gastric ulcer with hemorrhage |
K25.5 | Chronic or unspecified gastric ulcer with perforation |
K25.5 | Chronic or unspecified gastric ulcer with perforation |
K25.6 | Chronic or unspecified gastric ulcer with both hemorrhage and perforation |
K25.6 | Chronic or unspecified gastric ulcer with both hemorrhage and perforation |
K25.7 | Chronic gastric ulcer without hemorrhage or perforation |
K25.7 | Chronic gastric ulcer without hemorrhage or perforation |
K25.9 | Gastric ulcer, unspecified as acute or chronic, without hemorrhage or perforation |
K25.9 | Gastric ulcer, unspecified as acute or chronic, without hemorrhage or perforation |
K26 | Duodenal ulcer |
K26 | Duodenal ulcer |
K26.0 | Acute duodenal ulcer with hemorrhage |
K26.0 | Acute duodenal ulcer with hemorrhage |
K26.1 | Acute duodenal ulcer with perforation |
K26.1 | Acute duodenal ulcer with perforation |
K26.2 | Acute duodenal ulcer with both hemorrhage and perforation |
K26.2 | Acute duodenal ulcer with both hemorrhage and perforation |
K26.3 | Acute duodenal ulcer without hemorrhage or perforation |
K26.3 | Acute duodenal ulcer without hemorrhage or perforation |
K26.4 | Chronic or unspecified duodenal ulcer with hemorrhage |
K26.4 | Chronic or unspecified duodenal ulcer with hemorrhage |
K26.5 | Chronic or unspecified duodenal ulcer with perforation |
K26.5 | Chronic or unspecified duodenal ulcer with perforation |
K26.6 | Chronic or unspecified duodenal ulcer with both hemorrhage and perforation |
K26.6 | Chronic or unspecified duodenal ulcer with both hemorrhage and perforation |
K26.7 | Chronic duodenal ulcer without hemorrhage or perforation |
K26.7 | Chronic duodenal ulcer without hemorrhage or perforation |
K26.9 | Duodenal ulcer, unspecified as acute or chronic, without hemorrhage or perforation |
K26.9 | Duodenal ulcer, unspecified as acute or chronic, without hemorrhage or perforation |
K27 | Peptic ulcer, site unspecified |
K27.0 | Acute peptic ulcer, site unspecified, with hemorrhage |
K27.1 | Acute peptic ulcer, site unspecified, with perforation |
K27.2 | Acute peptic ulcer, site unspecified, with both hemorrhage and perforation |
K27.3 | Acute peptic ulcer, site unspecified, without hemorrhage or perforation |
K27.4 | Chronic or unspecified peptic ulcer, site unspecified, with hemorrhage |
K27.5 | Chronic or unspecified peptic ulcer, site unspecified, with perforation |
K27.6 | Chronic or unspecified peptic ulcer, site unspecified, with both hemorrhage and perforation |
K27.7 | Chronic peptic ulcer, site unspecified, without hemorrhage or perforation |
K27.9 | Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation |
K28 | Gastrojejunal ulcer |
K28.0 | Acute gastrojejunal ulcer with hemorrhage |
K28.1 | Acute gastrojejunal ulcer with perforation |
K28.2 | Acute gastrojejunal ulcer with both hemorrhage and perforation |
K28.3 | Acute gastrojejunal ulcer without hemorrhage or perforation |
K28.4 | Chronic or unspecified gastrojejunal ulcer with hemorrhage |
K28.5 | Chronic or unspecified gastrojejunal ulcer with perforation |
K28.6 | Chronic or unspecified gastrojejunal ulcer with both hemorrhage and perforation |
K28.7 | Chronic gastrojejunal ulcer without hemorrhage or perforation |
K28.9 | Gastrojejunal ulcer, unspecified as acute or chronic, without hemorrhage or perforation |
K30 | Functional dyspepsia |
K31.89 | Other diseases of stomach and duodenum |
K31.89 | Other diseases of stomach and duodenum |
P78.82 | Peptic ulcer of newborn |
R12 | Heartburn |